Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Pravastatin sodium |
Is a |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Adverse reaction caused by pravastatin (disorder) |
Causative agent (attribute) |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Allergy to pravastatin |
Causative agent (attribute) |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Product containing pravastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Product containing aspirin and pravastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 81 mg and pravastatin 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 81 mg and pravastatin 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Pravachol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Allergy to pravastatin |
Causative agent (attribute) |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Pravastatin sodium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
|
Aspirin 325 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Aspirin- and pravastatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pravastatin (substance) |
Inferred relationship |
Some |
2 |
Product containing pravastatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Product containing only aspirin and pravastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Product containing only pravastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Product containing only pravastatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin and pravastatin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 81 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pravastatin (substance) |
Inferred relationship |
Some |
1 |